The QualityStocks Daily Monday, March 20th, 2023

Today's Top 3 Investment Newsletters

SmallCapRelations(INM) $1.4600 +38.39%

PennyStockScholar(ALLR) $0.1439 +37.05%

MarketBeat(NYCB) $8.6100 +31.65%

The QualityStocks Daily Stock List

CVD Equipment (CVV)

Wall Street Resources, MarketBeat, QualityStocks, TradersPro, StreetInsider, CRWEFinance, Streetwise Reports, DrStockPick,, PennyToBuck, CRWEPicks, CRWEWallStreet, MarketClub Analysis, PennyOmega, SmarTrend Newsletters, StockHotTips, Outsider Club, Market Wrap Daily, BestOtc, TradingMarkets, TopStockAnalysts, The Street, Street Insider, Greenbackers, Zacks, StockMarketWatch, OTC Markets Group, Barchart, SmallCapVoice and FeedBlitz reported earlier on CVD Equipment (CVV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CVD Equipment Corporation (NASDAQ: CVV) (FRA: 0V3) is focused on designing, developing, manufacturing and selling process equipment and solutions which are utilized in the development and manufacture of coatings and materials for industrial and research applications.

The firm has its headquarters in Central Islip, New York and was incorporated in 1982, on October 13th by Leonard A. Rosenbaum. The firm serves consumers in the United States as well as internationally.

The company operates through the CVD Materials, SDC, Corporate and CVD segments. The corporate segment refers to the company’s administration activities which include anti-corrosion, customer support and process software services while the CVD materials segment provides material coatings for electronic, medical and aerospace applications. The SDC segment comprises of its ultra-high purity manufacturing division while the CVD segment is used for chemical vapor deposition equipment manufacturing. The company serves the solar photovoltaics, semiconductor, optoelectronics, nanomaterials, military, medical, glass coatings and aerospace markets.

The enterprise provides custom and standard fabricated quartz-ware used in various tools as well as its equipment. It also offers replacement and repair services for existing quartz-ware. In addition to this, the enterprise provides rapid thermal processing systems used in silicide formation. It also avails chemical vapor deposition systems which are utilized in researching, developing and manufacturing solar cells, carbon nanotubes and nanowires.

The company recently received a huge order from a major electric car battery material manufacturer in the U.S. With electric vehicle sales projected to grow significantly in the coming years, this contract will be helpful in extending the firm’s consumer reach in the sector and will also help bring in more opportunities and investments into the firm, which will have a positive effect on the company’s growth.

CVD Equipment (CVV), closed Monday's trading session at $13.2, up 11.2047%, on 39,840 volume. The average volume for the last 3 months is 3.734M and the stock's 52-week low/high is $3.68/$15.82.

Regis Corporation (RGS)

Streetwise Reports, Daily Markets, QualityStocks, MarketBeat, Zacks, StreetInsider,, Market Intelligence Center Alert, InvestorPlace, SmarTrend Newsletters, DrStockPick, StockMarketWatch, The Online Investor, CRWEPicks, CRWEFinance, Early Bird, Investor Guide, BUYINS.NET, BestOtc, CRWEWallStreet, PennyOmega, Barchart, RedChip, Zeke Truligio, SmartMoneyTrading, Stock Tips Network, StockHotTips, Street Insider, SystemTrading, The Motley Fool, Trades Of The Day, Trading Concepts and PennyToBuck reported earlier on Regis Corporation (RGS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Regis Corporation (NYSE: RGS) (FRA: RGI) is a franchisor, operator and owner of hair care and hairstyling salons around the globe.

The firm has its headquarters in Minneapolis, Minnesota and was incorporated in 1922 by Florence Kunin and Paul Kunin. It serves consumers around the globe, with a focus on Puerto Rico, Canada and the United States.

The company operates through the company-owned and franchise salon segments. It operates and franchises salons in 6 divisions, namely International, SmartStyle family hair salons, Trade Secret, MasterCuts, Strip center salons and Regis salons. Most of the company’s salons can be found in Wal-Mart stores, shopping centers and strip malls. Its salons mainly operate under the following trade names: First Choice Haircutters, Roosters, Cost Cutters, Open salon, Sassoon Saloon and Regis Salons. It derives the majority of its revenue from these locations.

The enterprise’s salons offer hair coloring, haircutting and styling services which include shampooing and conditioning. It also sells hair care and beauty products. Brands in the enterprise’s retail assortment include Moroccanoil, Kenra, Regis sexy hair concepts, Paul Mitchell and Biolage. It also provides an OpenSalon mobile app and a back-office salon management system known as OpenSalon Pro. In addition to this, the enterprise operates accredited cosmetology schools. It maintains ownership interests in the MY Style concepts in Japan and Empire Education Group in the United States.

The company recently announced its latest financial results, with its CEO noting that the firm was focused on increasing sales and driving its growth. Its growth will help encourage more investments into the firm.

Regis Corporation (RGS), closed Monday's trading session at $0.94, up 20.5128%, on 881,824 volume. The average volume for the last 3 months is 50.813M and the stock's 52-week low/high is $0.50/$2.34.

Blue Star Foods (BSFC)

QualityStocks, The Stock Dork, Schaeffer's and MarketBeat reported earlier on Blue Star Foods (BSFC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Blue Star Foods Corp. (NASDAQ: BSFC) is a global seafood firm that is engaged in the importation, packaging and sale of refrigerated pasteurized crab meat and other premium seafood products which are mainly sourced from Southeast Asia.

The firm has its headquarters in Miami, Florida and was incorporated in 1995, on May 15th by John Keeler. It operates as part of the grocery and related product merchant wholesalers’ industry. The firm has four companies in its corporate family and serves consumers around the globe.

The enterprise’s main business is the importation of red and blue swimming crab meat as well as steelhead salmon meat, mainly from China, the Philippines and Indonesia and distributing in in Canada and the United States, under different brand names. The crab meat it imports is processed in about 13 plants in Southeast Asia. The enterprise’s products include foil pouches, crab cakes, dips, toppings, stuffing, salads and crabmeat cocktails. It mainly sells its products to food service distributors, as well as to retail establishments, wholesalers and seafood distributors, under the Little Cedar Falls, Coastal Pride Fresh, Good Stuff, First Choice, Lubkin, Crab & Go Premium Seafood, Oceanica, Pacifika and the Blue Star brand names.

The company recently acquired an aquaculture system salmon farming operation known as Taste of Aquafarms. It believes that the recirculating aquaculture system is the future of the seafood industry and that this move will be sustainable over the long-term. This is in addition to creating stakeholder value and extending its consumer reach.

Blue Star Foods (BSFC), closed Monday's trading session at $0.1587, up 21.8894%, on 12,815,144 volume. The average volume for the last 3 months is 80,647 and the stock's 52-week low/high is $0.1302/$2.42.

Restaurant Brands New Zealand (RTBRF)

We reported earlier on Restaurant Brands New Zealand (RTBRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Restaurant Brands New Zealand Limited (OTC: RTBRF) (ASX: RBD) (NZE: RBD) operates quick service and takeaway restaurants in Australia, New Zealand, California, Hawaii, Guam and Saipan.

The firm has its headquarters in Penrose, New Zealand and was incorporated in 1997, on March 20th. It operates as part of the restaurants industry, under the consumer cyclical sector. The firm serves consumers around the globe.

The enterprise operates the Pizza Hut, KFC, Taco Bell and Carl’s Jr. brands in New Zealand; the KFC and Taco Bell brands in Australia; the KFC and Taco Bell brands in California; and the Taco Bell and Pizza Hut brands in Hawaii and Guam. It operates the New Zealand franchises for KFC, which is a fast-food restaurant chain; Pizza Hut, which provides a fast food online ordering system for pizzas, and Carl's Jr, which provides burgers, beverages and breakfasts. The enterprise has roughly 359 stores, including 105 KFC New Zealand, 71 KFC Australia, 70 KFC California (including 11 multi-brand KFC-Taco Bell stores), 37 Taco Bell Hawaii, 8 Taco Bell Australia, 10 Taco Bell New Zealand, 6 Pizza Hut New Zealand, 36 Pizza Hut Hawaii and 16 Carl’s Jr. New Zealand stores.

The company recently released its latest financial results, which show increases in its revenues. It remains focused on advancing its global growth strategy, which will not only bring in additional revenues into the company but also extend its consumer reach. This is in addition to opening it up to new growth and investment opportunities and creating shareholder value.

Restaurant Brands New Zealand (RTBRF), closed Monday's trading session at $4, up 2.5641%, on 200 volume. The average volume for the last 3 months is 191,963 and the stock's 52-week low/high is $3.4501/$9.68.

Connect Biopharma (CNTB)

MarketBeat and FreeRealTime reported earlier on Connect Biopharma (CNTB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Connect Biopharma Holdings Limited (NASDAQ: CNTB) is a clinical-stage biopharmaceutical firm that is focused on the development of therapies for the treatment of chronic inflammatory illnesses.

The firm has its headquarters in San Diego, California and was incorporated in 2015, on November 23rd by Wu Bin Pan and Zheng Wei. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

The company was founded by a team with broad knowledge of the drug discovery industry and expertise in targeting immunological pathways. Its subsidiaries include Connect Biopharma Hong Kong Limited and Connect Biopharm LLC, among others.

The enterprise is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is CBP-201, an antibody to target interleukin-4 receptor alpha in development for the treatment of atopic dermatitis (AD) and asthma. Other candidates in its pipeline include CBP-174, a peripherally acting antagonist of histamine receptor 3 in development for the treatment of pruritus associated with AD; and CBP-307, a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis.

The firm announced recently that 2 abstracts from its CBP-201 clinical development program in AD had been accepted for presentation at the American Academy of Dermatology. The success and approval of this candidate will not only benefit patients with this indication but also bring in additional investments into the firm.

Connect Biopharma (CNTB), closed Monday's trading session at $1.32, up 20%, on 14,823,848 volume. The average volume for the last 3 months is 191,298 and the stock's 52-week low/high is $0.5573/$4.175.

Asset Entities (ASST)

We reported earlier on Asset Entities (ASST), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Asset Entities Inc. (NASDAQ: ASST) is a technology firm that is engaged in the provision of social media marketing and content delivery services across different social media platforms, including Discord and TikTok.

The firm has its headquarters in Dallas, Texas and was incorporated in 2020. It operates as part of the internet content and information industry, under the communication services sector. The firm serves consumers in the United States.

The company’s vision is to spread life-changing financial literacy and in the process build a massive community of like-minded educated individuals where opportunities are continuously presented in every part of life. It operates as a subsidiary of Asset Entities Holdings LLC.

The enterprise also designs, develops and manages servers for communities on Discord. Its services comprise of Discord investment education and entertainment, social media and marketing, and AE.360.DDM services, which are based on the effective use of Discord as well as other social media including TikTok, Twitter, Instagram, and YouTube. Its AE.360.DDM, Design Develop Manage service (AE.360.DDM), is a suite of services for individuals and companies seeking to create a server on Discord. The enterprise’s brands include AE 360 DDM, DISCORD DISCOVERY, AE EDUCATION, REAL ESTATE, PODCASTS, AE MERCHANDISE and S. I. N.

The firm recently launched a marketing campaign for its AE.360.DDM services, to help address the growing social media management market. This move will extend its consumer reach, bring in additional revenues into the firm and bolster its overall growth.

Asset Entities (ASST), closed Monday's trading session at $1.75, up 10.0629%, on 606,484 volume. The average volume for the last 3 months is 1.175M and the stock's 52-week low/high is $1.43/$6.98.

Yellow Cake (YLLXF)

We reported earlier on Yellow Cake (YLLXF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Yellow Cake PLC (OTCQX: YLLXF) (LON: YCA) (FRA: 0LZ) is a specialist firm focused on the purchase and holding of uranium oxide concentrate (U308).

The firm has its headquarters in Saint Helier, the United Kingdom and was incorporated in 2018, on January 18th. It operates as part of the uranium industry, under the energy sector. The firm serves consumers in the United States, with a focus on those in the state of New Jersey.

The company offers direct exposure to the spot uranium price without exploration, development, mining or processing risk and to other commercial opportunities in the uranium sector. Its sole segment holds uranium oxide concentrate (U3O8) for long-term capital appreciation. The company is party to a long-term contract with NAC Kazatomprom JSC (Kazatomprom), the largest and one of the lowest cost producers of uranium globally.

The enterprise is also involved in uranium-related transactional activities, such as uranium location swaps. It is also involved in other operational and financial transactions on an opportunistic basis to secure exposure to uranium, including streaming and royalties and other financing opportunities. The enterprise holds roughly 18.8 million pounds of U3O8, which is held in a storage account at Cameco’s Port Hope/ Blind River facility in Ontario, Canada; and in Orano Cycle’s Malvesi/ Tricastin storage facility in France.

The firm is committed to supporting the move away from coal in energy generation, through the use of nuclear, which offers stable and low carbon baseload power. This will bring in additional revenues as well as investments into the firm while also encouraging more investments.

Yellow Cake (YLLXF), closed Monday's trading session at $4.8, up 1.0526%, on 150 volume. The average volume for the last 3 months is 3.218M and the stock's 52-week low/high is $3.75/$6.60.

MingZhu Logistics (YGMZ)

MarketClub Analysis, QualityStocks and BUYINS.NET reported earlier on MingZhu Logistics (YGMZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) is a transportation firm that is engaged in the provision of trucking and delivery services using its truckload fleet and subcontractors.

The firm has its headquarters in Shenzhen, China and was incorporated in 2002 by Jin Long Yang. It operates as part of the trucking industry, under the industrials sector. The firm serves consumers in the People’s Republic of China.

The company achieves constant innovation in logistics by bringing together great people and systems. It generates most of its revenue through the trucking service business.

The enterprise provides 4A-grade trucking services in China, offering both network density and broad geographic coverage to meet customers’ diverse transportation needs. It operates a self-owned truckload fleet with more than 130 tractors and 90 trailers. The enterprise’s transportation services are operated out of two terminals: Guangdong Province and Xinjiang Autonomous region, with both self-own fleets of tractors and trailers and subcontractors’ fleets. Its customers primarily include sizeable logistics companies, freight forwarders, and warehouse operators.

The company recently entered into a memorandum of understanding to acquire Guizhou Alliance Liquor Management Co Ltd, a distributor of Baijiu based in China. It also plans to invest in and develop a commercial liquor distribution business across China. This move will allow it to expand into the commercial liquor distribution market, generating additional revenues for the company. This is in addition to creating shareholder value, bringing in additional revenues and bolstering the company’s overall growth.

MingZhu Logistics (YGMZ), closed Monday's trading session at $1.18, up 4.4248%, on 30,848 volume. The average volume for the last 3 months is 222,582 and the stock's 52-week low/high is $0.78/$6.50.

Canaan Inc. (CAN)

QualityStocks, MarketClub Analysis, Schaeffer's, InvestorPlace, TradersPro, StreetInsider, MarketBeat, Stockhouse, AllPennyStocks, StockEarnings, INO Market Report, BUYINS.NET, InvestorsUnderground, Stock Fortune Teller, Trades Of The Day, StockMarketWatch, StocksEarning, The Online Investor, The Street, TopStockAnalysts and SmarTrend Newsletters reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Two masterminds of the post- 2008 Wall Street regulation system, Rep. Barney Frank and Senator Elizabeth Warren, yet again differ about what is causing banks to fold. While in office, Frank chaired the Committee for House Financial Services just as the global financial crisis hit and he wrote sweeping new rules for the financial sector. He also served as a member on the Board of the New York Signature Bank which was shut down recently.

Frank blames Signature’s fall on the crypto panic that started last year. His bank was one of the privileged few that served the industry. A bipartisan regulatory roll back ascented into law by former president Trump in 2018 was fueled by the desire to even the regulation of mid- sized banks like his own, though it had no impact, Frank argues.

But a fellow Massachusetts democrat, Senator Elizabeth Warren, lays the blame squarely on the former president Trump. Trump’s era eased some bank oversight and Signature Bank is a very good example. She claims that if Congress and Federal Reserve had not rolled back the stricter oversight, Signature and Silicon Valley banks could have withstood the financial shocks.

The gap between the two Democrats is a premonition of what is to come while Democrats align positions on how to tackle the most recent banking crisis that culminated into the bail out of Signature and Silicon Bank depositors over the weekend. Frank said he and other lenders ran into trouble with the federal loans bank at a time Signature was applying for money, and the Federal Loan Bank told Signature Bank that they didn’t have much to go around owing to the too many requests they were getting.

Frank and Warren seem to agree on one issue – their support for bigger depositor protection. The Federal Deposit Cnsurance caps its protection at $25,000 though regulators and the Biden administration pledged to fund all the deposits at the banks that went belly up.

Regulators must reform the deposit insurance in this crisis so that in the future, enterprises seeking to make payroll are fully covered, Frank commented in a New York Times op-ed. Frank is happy that the government has vindicated him through their decision to guarantee deposits because during his tenure as a Republican, he desired to pass the legislation that would expand the deposit insurance specifically for business.

Meanwhile, the wider cryptocurrency industry and its leading actors like Canaan Inc. (NASDAQ: CAN) awaits the formulation of comprehensive regulations which can serve as guideposts to the entities operating in this space.

Canaan Inc. (CAN), closed Monday's trading session at $2.89, off by 6.1688%, on 2,050,416 volume. The average volume for the last 3 months is 342,154 and the stock's 52-week low/high is $1.87/$6.90.

Workhorse Group Inc. (WKHS)

Green Car Stocks, InvestorPlace, MarketClub Analysis, Schaeffer's, QualityStocks, Kiplinger Today, MarketBeat, StockMarketWatch, StocksEarning, TradersPro, StreetInsider, Early Bird, The Street, Trades Of The Day, Daily Trade Alert, The Online Investor, TraderPower, TopPennyStockMovers, Zacks, BUYINS.NET, Wealth Insider Alert, Cabot Wealth, InvestorsUnderground, Jason Bond,, PoliticsAndMyPortfolio, StockEarnings, StockOodles, Stock Beast, Wealth Daily, Energy and Capital, The Best Newsletters, Daily Market Beat, The Wealth Report and Profitable Trader Authority reported earlier on Workhorse Group Inc. (WKHS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

According to a recent report by the Environmental Defense Fund and WSP USA, the IRA and other national measures have stimulated already booming investments in EV production facilities as well as batteries used in powering them in the United States. Investment totaling more than $120 billion and 143,000 newly created jobs in the manufacturing industry in the United States have indeed been reported during the past eight years. More than 40 % of the announcements have occurred in the past six months, after the Inflation Reduction Act’s adoption.

According to Peter Zalzal, a vehicle manufacturing renaissance in America has begun in slightly over a year, thanks to unprecedented investments made in the Bipartisan Infrastructure and IRA Acts. The analysis demonstrates how the American states are competing for the best investment as well as the jobs related to the production of electric cars, across Michigan to Nevada to Georgia.

These previously mentioned manufacturing facilities in the United States will be capable of producing an estimated 4.3 million new electric vehicles and passenger trucks annually in the year 2026. For contrast, that is around one-third of total new car sales in the United States in 2016.

The research reveals significantly higher investment levels in American battery production. The previously announced facilities in the United States will be capable of producing sufficient batteries by the year 2026 to provide more than 11,000,000 additional zero-emission passenger vehicles annually, or more than 80% of all new cars produced in the past one year.

The huge investment sparked by the latest federal policies, such as the IRA, will directly facilitate jobs throughout the American states. Out of the investments announced, 86% are focused in only 10 American states, with more than $10 billion worth of investment being made in each of these five states — Michigan, Georgia, Tennessee, Kentucky and Nevada — alone in order to support the creation of 10,000 new jobs or more in each of the aforementioned states, as well as in North and South Carolina.

The analysis also determined that investment, manufacturing capability and availability of jobs in the EV industry will likely spur further growth as a result of anticipated government initiatives in the future, such as national vehicle emissions requirements for vehicles and passenger trucks. Concerning heavy-duty and medium vehicles, such as buses and cargo trucks, the EPA is also anticipated to shortly put forward emission regulations based on performance.

According to Zalzal, the EPA has a crucial chance of establishing future national pollution regulations for heavy-duty, medium and light vehicles, which must reflect and expand upon these significant investments in order to minimize pollution that harms the environment and human health, save customers money and support excellent jobs.

With companies such as Workhorse Group Inc. (NASDAQ: WKHS) continuing to pour money into their EV programs, a lot more jobs and different vehicle models are going to be available over the coming years.

Workhorse Group Inc. (WKHS), closed Monday's trading session at $1.38, off by 5.4795%, on 6,254,584 volume. The average volume for the last 3 months is 4.189M and the stock's 52-week low/high is $1.36/$5.39.

Seelos Therapeutics Inc. (SEEL)

QualityStocks, MarketBeat, StockMarketWatch, MarketClub Analysis, TradersPro, Schaeffer's, BUYINS.NET, Trades Of The Day and INO Market Report reported earlier on Seelos Therapeutics Inc. (SEEL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Psychedelics have emerged as a viable alternative to traditional mental health therapies in recent years. A surge in psychedelic research has revealed that hallucinogenic drugs such as ketamine, MDMA, LSD and psilocybin (magic mushrooms) are capable of treating numerous mental health disorders.

Studies have shown that these psychedelics can deliver potent and long-term mental health benefits when paired with talk therapy and at relatively minimal doses. While most of this research is still in its infancy, results from prior studies have been so compelling that lawmakers across the United States are working on legislation to either decriminalize psychedelics or sanction their use in medical settings.

As the scientific literature on psychedelics as mental health treatments steadily increases, more people are considering hallucinogenics as a salve for their mental health issues rather than traditional treatments such as pharmaceuticals and talk therapy.

Couple therapy is one field that may be disrupted by the proliferation of psychedelic-assisted therapy in the near future. One couple in New Mexico, for instance, first tried MDMA (ecstasy) two years ago thinking that they were into a fun experience akin to smoking a little cannabis to unwind. However, while under the influence of the psychedelic, 37-year-old Joe and his wife discussed the trash, talked about why Joe didn’t take it out more often and came to a compromise.

Joe says that the psychedelic opened doors they “didn’t even know were there” and allowed them to hash out the trash issue. These days, the couple dedicates a few nights a year where they rent a hotel room, consume a little ecstasy and talk about key issues in their marriage, such as the division of labor in the home, parenting and sex. According to Joe, discussing such big issues doesn’t seem like a big deal while they are under the influence.

Although MDMA therapy is currently illegal under federal law, experts in the nascent psychedelic-assisted treatment field expect the FDA to approve the use of MDMA in PTSD treatment in the next two years. Once this happens, other uses of MDMA, such as assisting couples therapy could become viable.

Assistant professor of psychiatry and behavioral sciences at Johns Hopkins Medicine Albert Garcia-Romeu notes that there are plenty of neurobiological reasons for the potential effectiveness of psychedelics in couples therapy. By encouraging the release of bonding hormones such as oxytocin and stoking the activity of feel-good neurotransmitters, psychedelics such as MDMA can erode inhibition, and release fear and tension while building trust.

This in turn helps people to talk about and revisit traumatic or difficult topics without experiencing major emotional reactions, allowing them to temporarily lower their guard down and “clear out a lot of emotional baggage.”

Plenty of startups such as Seelos Therapeutics Inc. (NASDAQ: SEEL) are investing considerable resources in developing psychedelic-based treatments for not just mental but also other physiological ailments. The findings of their studies promise to be interesting and eye-opening for individuals looking to learn about the full potential of this field of therapeutic hallucinogens.

Seelos Therapeutics Inc. (SEEL), closed Monday's trading session at $0.69, up 4.1352%, on 672,949 volume. The average volume for the last 3 months is 12.638M and the stock's 52-week low/high is $0.4803/$1.52.

Astra Energy Inc. (ASRE)

We reported earlier on Astra Energy Inc. (ASRE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Astra Energy (OTCQB: ASRE) today announced its receipt of a commitment letter from the revolutionary government of Zanzibar to supply approximately 200 acres of land by way of a 33-year renewable lease, for Astra’s proposed Zanzibar Clean and Renewable Energy Park Project (“Project”). The Project will generate 50MW of clean and renewable energy on Unguja, the largest island in the Zanzibar Archipelago and the seat of Zanzibar’s semi-autonomous government. It will comprise of 42.5 megawatts of solar generation, coupled with Astra’s proprietary Regreen waste-to-energy technology, which will generate the remaining 7.5 megawatts and consume and eliminate approximately 300 tons of municipal solid waste (“MSW”) daily. The Project will also include a battery energy storage system (BESS), a peak power source and much-needed source of grid stability for the island. “Astra conceived this unique Project to address two of Zanzibar’s most pressing issues: access to clean, reliable power and the growing problem of municipal solid waste disposal,” said Astra’s Vice President of Electrical Power Generation Tony Thompson. “The 50 megawatts of generation on Unguja, coupled with the BESS component, will drastically reduce the island’s reliance on a single 100-MW submarine cable from mainland Tanzania, which is currently its sole source of power and is routinely operated at greater than 90% of its capacity during periods of peak demand on the island. The Project’s consumption of 300 tons per day of MSW will reduce the stress on the Kibele landfill, the island’s only dedicated receptacle for waste.”

To view the full press release, visit

About Astra Energy Inc.

Astra Energy is an integrated solutions provider investing in and developing renewable and clean energy projects in markets where demand is high, supply is limited and there is an opportunity to address other imminent market needs. Astra’s corporate strategy is rooted in securing technologies and assets; identifying viable market opportunities; and bringing together resources, expertise, technology and defined action plans to execute first-in-class projects that benefit communities, local economies, the planet and the company’s investors. Its goal is to create a more secure and sustainable power sector that supports the company’s purpose, mission and values to transform the economic, environmental and social landscape for generations to come. For more information on Astra Energy, visit the company’s website at

Astra Energy Inc. (ASRE), closed Monday's trading session at $0.22, even for the day, on 58,763 volume. The average volume for the last 3 months is 1,629 and the stock's 52-week low/high is $0.0801/$6.1875.

The QualityStocks Company Corner

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF)

The QualityStocks Daily Newsletter would like to spotlight Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF).

Canadian mining company Ivanhoe Mines saw its profits from lastyear soar due to record copper sales. A recently published statement from the mining firm revealed that it sold 323,733 tons of payablecopper last year and generated a record annual revenue of $2.15billion. Ivanhoe’s total profit for the year stood at a whopping$434 million and could primarily be attributed to the company’sKamoa-Kakula joint venture, which brought in around $405 million.In the south of the Democratic Republic of Congo in the KolweziDistrict of Lualaba, the Kamoa-Lakula Copper Complex produced morethan 333,000 tons of copper and sold 92,208 tons of payable copperlast year. The complex is a joint venture between Ivanhoe Mines(which owns a 39.6% stake), Zjin Mining Group (with a 20% stake), the DRC government (with a 20% stake) andCrystal River Global (holding a 0.8% stake). The Kamoa-Kakula mine generated a whopping $2.15 billion in revenue and contributed tomost of Ivanhoe’s record 2022 profits. It is now undergoing the third phase of an expansion project that is expected to be finished by late 2024. This phase involvesthe construction of another 5-million-ton-per-annum accelerator atKamoa and replacing a turbine at the complex’s hydroelectric powerstation. The new turbine will supply 178MW of power to the nationalgrid, and it will also generate electricity for the third phase ofexpansion. Other copper exploration and extraction companies suchas Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) are likely to make bolder plans for the future given how bullishthe outlook is for this green energy metal.

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) is a mineral exploration company engaged in advancing precious and base metal deposits in the state of Arizona. Its flagship copper-gold-zinc-silver asset is the Kay Mine Project, located in Yavapai County. The company also owns Sugarloaf Peak gold project in La Paz County.

The company in October 2022 received permit approval from the Bureau of Land Management (BLM) for two new drill pads, located approximately 1,200 meters west of the Kay Mine Deposit. These new pads will allow for testing of the company’s Western Target, while also allowing for drilling of additional coincident anomalies located between the Central and Western Targets. Construction of the drill road for the Central Target (located 500 meters west of the Kay Mine Deposit) is currently underway, with drilling expected to begin in November 2022. Road construction for the Western Target will begin upon confirmation of BLM acceptance of the company’s posted bond, with drilling expected to commence in Q1 2023.

The company is fully funded, with $60 million in cash as of June 30, 2022, to complete the remaining 18,000 meters planned for the Phase 2 program at Kay, as well as an additional 76,000 meters in the Phase 3 program (budgeted at $27 million), which will be used to test the numerous parallel targets heading west of the Kay Deposit, as well as the northern and southern extensions of the Kay Deposit.

Arizona Metals Corp. is based in Toronto, Canada.


Arizona Metals Corp. owns 100% of the Kay Mine property in Yavapai County, which is located on a combination of patented and BLM claims totaling 1,300 acres that are not subject to any royalties. An historic estimate by Exxon Minerals in 1982 reported a “proven and probable reserve of 6.4 million short tons at a grade of 2.2% copper, 2.8 grams per ton gold, 3.03% zinc, and 55 grams per ton silver.” The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported by Exxon, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a “qualified person” (as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects) before the historic estimate can be verified and upgraded to be a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

The company also owns 100% of the Sugarloaf Peak Property in La Paz County, which is located on 4,400 acres of BLM claims. Sugarloaf is a heap-leach, open-pit target and has a historic estimate of “100 million tons containing 1.5 million ounces (of) gold” at a grade of 0.5 grams per ton. The historic estimate at the Sugarloaf Peak Property was reported by Westworld Resources in 1983. The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a qualified person before the historic estimate can be verified and upgraded to a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, reports that global demand for gold during the first six months of 2022 was 2,189 tons, a 12% increase in demand over the same period in 2021. Demand came primarily from gold bar and coin investors, jewelry consumers, central bank purchases to bolster currency reserves and technology manufacturing.

The average price per ounce for the period was $1,871, marking a 1% year-over-year increase. The council reported gold mine production for the period was up 3% over 2021 at 1,764 tons. For the remainder of 2022 and into 2023, the council projects flat gold demand with possible slight increases in gold mine production. The council notes that unpredictable geopolitical factors, the Ukraine war for example, and likelihood of global economic slowdown could have significant near-term impact on gold demand and prices.

Management Team

Marc Pais is President and CEO of Arizona Metals. He previously founded and served as President of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. He has seven years of experience as a Mining Analyst, with a focus on precious metals development companies. He holds a B.Sc. in Geological Engineering (Mineral Exploration) from Queen’s University in Canada.

David Smith is the Vice President, Exploration of Arizona Metals. He has 30 years of global precious metals exploration experience, including codiscovery of the Solidaridad/La Sabila deposit in Mexico with deposits estimated at 1 million ounces of gold. His core areas of expertise are managing mineral projects from acquisition to exploration, resource modeling and mineral project development. He holds an M.Sc. from the University of Oregon and an MBA from Pinchot University/Presidio Graduate School.

Paul Reid is the Executive Chairman of Arizona Metals. He previously founded and served as Executive Chairman of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. Paul has extensive experience as an Investment Banking professional, involved in raising capital, go-public transactions, and advisory services.

Vision Energy Corp. (OTCQX: AZMCF), closed Monday's trading session at $3.05, up 1.6667%, on 76,845 volume. The average volume for the last 3 months is 11,403 and the stock's 52-week low/high is $2.30/$5.60.

Recent News

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT) .

New data show rising burden of most cardiovascular risk factorsamong young adults aged 20 to 44 in the U.S.

Findings are “extremely concerning” as expert notes “we’rewitnessing a smoldering public health crisis”

HeartBeam has developed the first and only 3D-vectorelectrocardiogram for heart attack detection anytime, anywhere

A recent study shows that risk factors for cardiovascular (“CV”)disease are rising among young adults ( Studies like this that provide critical information regarding CVdisease highlight the ongoing urgency of HeartBeam’s efforts. HeartBeam (NASDAQ: BEAT) is a cardiac technology company that has developed the first andonly 3D-vector electrocardiogram for heart attack detectionanytime, anywhere.

HeartBeam Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector 12-lead electrocardiogram (ECG) platform for heart attack detection anytime, anywhere. The company’s proprietary ECG telehealth technology aims to redefine the way high risk cardiovascular patients are diagnosed in ambulatory and acute care settings. HeartBeam’s initial focus is on providing diagnostic data to help physicians with care management of patients with cardiovascular disease.

In August 2022, HeartBeam announced that it submitted its HeartBeam AIMI™ software for approval from the U.S. Food and Drug Administration (FDA). HeartBeam AIMI is a platform technology to improve the speed and accuracy of heart attack detection in acute care settings. The company expects FDA approval by the end of 2022, and a full commercial roll-out of HeartBeam AIMI is targeted for Q1 2023.

HeartBeam sees submission of its first product based on its platform technology as an important milestone toward commercialization, which underscores the company’s continued progress toward making the HeartBeam AIMI platform widely available to help emergency department physicians quickly and accurately identify a heart attack.

While the FDA conducts its regulatory review, HeartBeam will focus on executing key components of its commercialization plan and subscription revenue model. It will also continue to engage in discussions with strategic institutions, including academic centers, regional healthcare systems and regional community hospital systems that can utilize HeartBeam products.

The company is based in Santa Clara, California.


HeartBeam’s development portfolio includes two products:

  • HeartBeam AIMI is software that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack in acute care settings and, as noted above, has been submitted for FDA approval; and
  • HeartBeam AIMIGo™, the first and only credit card-sized 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system for remote heart attack detection.

HeartBeam is developing AIMIGo, a medical-grade detection and monitoring technology for use in remote heart attack detection, thereby allowing physicians to diagnose a patient’s heart attack as it occurs, even if the patient is not at a medical facility. The company’s system, once approved by the FDA, can be used by patients at home or almost anywhere and anytime to help their physicians assess whether chest pain is the result of a heart attack or another cause. While approximately 82% of chest pain ED visits are unnecessary, patients delay approximately 3 to 4 hours after symptoms begin, increasing mortality rates by 40%. The company’s goal is to shorten the time to treatment outside of the medical facility to improve patients’ well-being.

HeartBeam’s AIMIGo is a powerful, portable and easy-to-use prescription-based product. It comprises a smartphone app, a credit card-sized ECG device placed on a patient’s chest, the HeartBeam cloud platform, and a digital portal for the physician to view ECG results and direct patient action. For the first time outside of a medical setting, HeartBeam AIMIGo enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if needed.

Pending FDA clearance, AIMIGo is initially intended to be available by prescription, and is reimbursable under existing remote patient monitoring codes (RPM codes). This provides a new revenue stream to physicians who before did not have a way to monitor these high-risk patients. The RPM codes provide a monthly reoccurring revenue stream to the company, as well. On average, at current reimbursement rates, the practice will receive $1,300+ per year per patient they monitor, and the company will receive $600 per year per patient from this RPM reimbursement.

Market Overview

Adoption rates of telehealth services increased dramatically in recent years, with the COVID-19 pandemic serving as a major driver of growth. Among the areas seeing the greatest expansion are cardiology, radiology, behavioral health and online consultation.

Encouraging this growth, governments are actively developing new policies and reimbursement guidelines to promote the use of digital health platforms. The U.S. Centers for Medicare & Medicaid Services (CMS), for example, has recently expanded reimbursement for telehealth services. U.S. market growth is also being driven by the rising prevalence of chronic conditions and the growing geriatric population.

Remote heart attack detection is a previously unsolved problem with a massive and underserved market that is several times larger than the $2 billion total addressable market (TAM) in the U.S. for ECG cardiac arrhythmia monitoring.

Approximately 8 million Americans have suffered at least one heart attack, and a total of 18 million have been diagnosed with coronary artery disease (CAD). Based on these figures, HeartBeam projects a total addressable U.S. market TAM valued at $10 billion annually for its AIMIGo solution for remote heart attack monitoring of CAD.

Management Team

Branislav Vajdic, Ph.D., Chief Executive Officer and Founder of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the company. Prior to HeartBeam, from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space. From 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management position. At Intel, Dr. Vajdic was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs. Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is author of numerous patents and publications in the fields of cardiovascular devices, as well as chip design. Dr. Vajdic holds a Ph.D. in Electrical Engineering from the University of Minnesota.

Jon Hunt, Ph.D., has over 35 years’ experience in the medical/medical device industry with extensive domestic and international experience in general management, clinical/regulatory, sales and marketing. He also has diverse experience in Fortune 500 companies, as well as start-up environments. Dr. Hunt was the Vice President of Clinical Science and Technology, Medical Device Innovation Consortium, from July 2019 to July 2021, and Vice President of Clinical and Regulatory Affairs, Cryterion Medical from January 2018 to June 2019 (acquired by Boston Scientific Corporation in July 2018 for $202M). Dr. Hunt was the Founding President and CEO of Bardy Diagnostics, Inc. from October 2013 to November 2017 (acquired by Hill-Rom Holdings, Inc.). Prior to joining Bardy Diagnostics, Dr. Hunt spent the previous 11 years as the Vice President of Clinical & Regulatory Affairs with Cameron Health, Inc. (acquired by Boston Scientific Corporation). Dr. Hunt spent the previous 10 years with Cardiac Pacemakers, Inc., St. Jude Medical and Cardiac Pathways Corporation. Dr. Hunt began his career with Cardiac Pacemakers, Inc. (now Boston Scientific Corporation) as the Director of Clinical Programs. He subsequently held positions at St. Jude Medical in Clinical Affairs and as the Business Unit Director for the Cardiac Rhythm Management division for Europe, the Middle East and Africa. At Cardiac Pathways Corporation, Dr. Hunt held various executive positions as Vice President of International Sales and Marketing and Vice President of Worldwide Sales and Marketing (acquired by Boston Scientific Corporation). Dr. Hunt received his Ph.D. in Motor Control from The Pennsylvania State University, his Master’s from California State University, Long Beach and his undergraduate degree from Keele University in the United Kingdom.

Rick Brounstein, HeartBeam’s Chief Financial Officer, combines over 30 years of experience in health technology senior management. Since 2017, Mr. Brounstein has been and is currently a partner of Hardesty, LLC, a financial services firm, and Mr. Brounstein is currently a managing director of CTRLCFO, LLC, a firm Mr. Brounstein founded in 2016 to support funded start-ups in life science and technology. From 2008 to 2011, Mr. Brounstein was Chief Financial Officer of NewCardio, Inc., a microcap public company in the cardiology space, and, over his career, he has been with nine other companies in life science or technology, holding positions including Chief Financial Officer, Chief Operating Officer, Treasurer and Accounting Manager. From June 2001 through November 2007, Mr. Brounstein held several positions at Calypte Biomedical Corporation, a publicly traded medical device company, including Chief Financial Officer and Executive Vice President. In January 2007, Mr. Brounstein was appointed as the National Member Representative for the 2007 COSO Monitoring Project, which published new guidelines for monitoring internal financial controls in February 2009; Mr. Brounstein subsequently was a member of the FEI task force that issued the updated COSO Internal Control Framework in 2013. In March 2005, Mr. Brounstein was appointed to the SEC Advisory Committee on Smaller Public Companies. Mr. Brounstein earned his Certified Public Accountant (CPA) certification while working at Arthur Andersen LLP, formerly a public accounting firm. Mr. Brounstein holds a B.A. in accounting and an M.B.A. in finance, both from Michigan State University.

Ken Persen, HeartBeam’s Chief Technology Officer, combines over 28 years of experience in the medical device and digital health industries in engineering and senior management positions. Mr. Persen has been involved in several companies in Cardiac Rhythm Management, holding positions including Chief Executive Officer, Chief Technology Officer, Executive Vice President and Director of Engineering. Since 2016 and prior to joining HeartBeam, Mr. Persen was the Chief Technology Officer at LIVMOR, Inc., a digital health company. In addition, from 2016 through November 2021, he was also Chief Executive Officer of LIVMOR. Prior roles included Director of Engineering at Cameron Health (acquired by Boston Scientific), a late-stage medical device start up, and engineering and management positions at Guidant Corp. (acquired by Boston Scientific), a large medical device manufacturer. He has an undergraduate degree from University of Minnesota, Duluth, with a BA in Computer Science.

HeartBeam Inc. (NASDAQ: BEAT), closed Monday's trading session at $2.4, up 15.3846%, on 89,354 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $5.60/$.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Rare earth element (“REE”) processing solutions developer UcoreRare Metals Inc. is preparing to demonstrate the prowess of itsproprietary RapidSX (TM) technological advantage as an improvementover standard REE ore separation processes

REE production has become a matter of strategic importance toAmerican industries and tech-based military applications, as Chinahas built global control of vital REE markets and demonstrated awillingness to stop REE exports during international disputes

Ucore is preparing to launch construction of a Strategic MetalsComplex (“SMC”) in Louisiana later this year after demonstratingRapidSX (TM) potential at its Canadian base

Ucore’s SMC will be the first in a series of processing facilitiesdrawing on “allied” Western ore sources for rapid throughput ofREEs to market in North America

The company also owns an REE mine prospect in Alaska that itintends to start up once financing is secured

Tensions in an evolving tech war between the United States andChina grew this month as the Netherlands announced it would agreeto limit the export of “advanced” semiconductor manufacturingequipment ( as a result of an agreement it quietly ratified with Japan andthe United States in January ( export limits, which tacitly are aimed at restraining China’sworld dominance in mining resources for next-generation technologyused in everything from cell phones and electric vehicles tomilitary assets, demonstrate the cooperative efforts Westerngovernments and industries are undertaking to prevent becomingdependent on the Asian nation, whose population and economy (whenmeasured by purchasing power parity) are the largest on earth ( Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a Canadian company developing specialized rare earth element(“REE”) separation and processing solutions, is playing a role inreasserting North America’s independence in tech resource mining.The company is preparing to demonstrate its proprietary RapidSX(TM) process for the low-cost separation and purification of REEsthrough an accelerated form of solvent extraction at aDemonstration Plant in Ontario.

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is engaged in Rare Earth Element (REE) resource development and in commercializing its critical metals separation technology, RapidSX™, for the mining and metals extraction industry. The company is guided by principles of environmental, social and corporate governance (ESG) with a focus on disrupting China’s current dominance of the U.S. REE supply chain.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. It plans to aid in the development, through strategic partnerships, of a North American REE supply chain controlled by the U.S. and its allies.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (SMCs) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (HREE) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Demonstration Plant

The Kingston, Ontario, RapidSX™ Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

  • The techno-economic advantages of the RapidSX technology platform
  • The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
  • The platform’s ability to operate for thousands of semi-continuous run-time hours
  • Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials

The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX™ Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (SX) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (SMC). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

Ucore Rare Metals Inc. (UURAF), closed Monday's trading session at $0.98843, up 7.6369%, on 41,488 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.40/$1.15.

Recent News

GeoSolar Technologies Inc.

The QualityStocks Daily Newsletter would like to spotlight GeoSolar Technologies Inc.

A recent report published by the IEA revealed that global carbonemissions rose by 0.9% YoY in 2022, hitting a record 36.8 gigatons

With households accounting for 30% of global greenhouse gasemissions, GeoSolar Technologies has focused on building outrenewable energy solutions for homes

U.S. households have been slow to adopt renewable energy. As of2020, only 3.7% of U.S. households derived their electricity fromsolar energy versus nearly 33% in Australia

The recently passed Inflation Reduction Act (“IRA”) in the U.S.will seek to augment that figure in the U.S., with homeowners ableto benefit from an array of tax credits and rebates on anypurchases of energy efficient technology

Global carbon emissions hit a new record in 2022 according to anewly published report by the International Energy Agency (“IEA”),with emissions of the greenhouse gas rising by 0.9 percentyear-over-year to 36.8 gigatons – the physical equivalent of 3.6million fully loaded aircraft carriers ( What makes the statistic even more remarkable is the contextunder which it was achieved. China emits 27 percent of the world’scarbon dioxide output and accounts for upwards of a third of globalgreenhouse gas emissions, yet for much of the past year, thenation’s economy has found itself at a virtual standstill – abyproduct of the Chinese government’s stringent Zero Covidpolicies. Accordingly, the publication of the IEA’s report has beenmet with some consternation by the global scientific community.“Any emissions growth — even 1% — is a failure,” said Rob Jackson,a professor of earth system science at Stanford University andchairman of the Global Carbon Project, an international group. “Wecan’t afford growth. We can’t afford stasis. It’s cuts or chaos forthe planet. Any year with higher coal emissions is a bad year forour health and for the Earth.”GeoSolar Technologies (“GST”), a Colorado-based climate technology company pioneering anapproach into clean energy solutions for households, has centeredtheir corporate mission around reducing household carbon emissions– a critical objective in terms of achieving global Net Zeroambitions. Through the introduction of its proprietary SmartGreen™Home system, an environmentally friendly, renewable energy focusedtechnology designed to harness energy from the earth and sun topower and purify homes and automobiles without the use of fossilfuels, GeoSolar have looked to tackle the astounding thirty percentof global greenhouse gases generated by households every year.Moreover, and during a time of increasingly elevated electricitycosts, the Company revealed that the average GeoSolar-powered homecould result in a negligible carbon footprint with homeownersdisbursing less than $100 per annum in utility bills (

GeoSolar Technologies Inc. (“GST”) is a Colorado-based climate technology company and the creator of the Smart Green Home® system for newly built and existing residences and commercial buildings. The company is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources. Its patent-pending integrated system harnesses energy from the earth and sun to power and purify homes and automobiles without the use of fossil fuels.

In a GST home, the sun’s energy is captured on the roof to generate all of the electricity required. Additionally, the consistent climate of the earth is used to keep the home at a perfect temperature year-round, and the company’s proprietary air purifying unit ensures that the air inside the home is safe and healthy.

GST’s home technology has been installed in multiple test homes in Colorado and achieved exceptional results, including some of the most impressive energy efficiency ratings (HERS) in the industry.

GeoSolar Technologies is currently accepting investment as part of a Regulation A+ offering. Everyone* can invest now for as little as $300. For more information, visit the company’s profile on Manhattan Street Capital and review its Offering Circular.

GeoSolar Technologies Inc. (“GST”) has been qualified by the U.S. Securities and Exchange Commission (SEC) to conduct a Regulation A+ capital raise. GST is already a publicly traded company who makes quarterly and annual filings with the SEC and is subject to quarterly PCAOB audits. This is the first time shares of GeoSolar Technologies are being made available for public purchase. Upon completion of this Regulation A+ offering, the company intends to seek a listing of its stock.


The Decarbonization Movement

Soaring and unstable energy/fuel costs continue to highlight the importance of rethinking the traditional approach to powering homes, from top to bottom. While most everyone is well aware of the remarkable, multi-trillion-dollar opportunity the electric vehicle transformation offers to investors (in addition to the benefits to the climate problem), few recognize that the all-electric home market is as large as electric vehicles and equally important to reducing carbon emissions.

U.S. energy expenditures clocked in at $3,891 per person in 2018, leading to estimated spending of $1.3 trillion on energy that year alone. Despite this, fewer than 3% of U.S. homes are currently powered by solar. This number is poised to increase exponentially as both new and existing residences transition to zero carbon models.

GST estimates that if all the homes in America were powered by its technology, carbon pollution could be reduced by an estimated 1.9 trillion pounds per year, greatly reducing the negative impacts on our climate.


The GeoSolarPlus (“GSP”) system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system.
Key benefits of the GSP system include:

  • Making a real planet-changing difference in reducing air pollution
  • Eliminating or significantly reducing homeowners’ future utility bills
  • Enjoying lifetime energy independence and protection from price escalation and energy shortages
  • Eliminating greenhouse gas emissions from operation of home and daily life
  • Increasing home value
  • An integrated design for seamless operation of renewable energy systems
  • Maintaining a significantly healthier living environment
  • Leveraging existing renewable energy tax credits and electrification incentives
  • Creating stable jobs capable of supporting families in the decarbonized future

Click here to learn more about how GeoSolarPlus works.

Management Team

The GST leadership and management team includes some of the world’s most experienced and respected leaders in the fields of decarbonization and sustainable homes.

Stone Douglass is the Chairman and CEO of GST. He is a seasoned, 30-year public company executive and former Chairman and CEO of the Piper Aircraft Company.

Brent Mosbarger is the company’s Co-Founder and leads its commercial operations. He is a highly respected solar engineer whose experience includes roles with Chevron Energy’s green operations and serving as project manager and executive for a $400 million solar/geothermal innovation project.

Peter Romenesko is a Senior Strategic Advisor with GST. He brings to the company considerable experience as an engineer and large-scale project manager for Johnson Controls and Siemens.

Dr. Norbert Klebl is the company’s Co-Founder and Development Director. Recognized as one of the world’s leading experts in the field of zero-carbon innovation, he is a former McKinsey partner of 16 years with an MBA from Columbia.

Dar-Lon Chang is GST’s Director of New Product Development. Prior to joining GST, he had a 16-year career with ExxonMobil Energy Research. He received his PhD in engineering from the University of Illinois.

* Must be over 18, certain states are not currently available and will be added soon.

Recent News


CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

Around 700,000 Americans are estimated to be living with a primarybrain tumor. The deadly condition has an incredibly high fatality rate, and it significantly disrupts the quality of life of brain cancerpatients and their families. Although tumors can’t be completelycured, early detection can allow doctors to deploy treatments suchas radiotherapy and chemotherapy to kill off cancer cells andreduce the size of the tumor. Even so, researchers are constantlysearching for novel treatment options that are capable of treatingtumors more effectively and with fewer side effects on the patient.Investigators from Massachusetts General Hospital recently published a study suggesting that normalizing the blood vessels in tumors couldpotentially improve the effectiveness of brain cancerimmunotherapy. Immunotherapy is a relatively novel means of cancer treatment that boosts orchanges the body’s immune system and helps it fight off cancercells on its own. The promise of manipulating angiogenesis in braintumors to boost treatment effectiveness could be a direction thatmany companies such as CNS Pharmaceuticals Inc. (NASDAQ: CNSP) look into in the coming years to see how their drug-developmentpipelines can benefit from this discovery.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Monday's trading session at $1.09, off by 2.6786%, on 42,395 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.9903/$13.425.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

Boston Consulting Group estimates the near-term total addressablemarket (“TAM”) for quantum hardware, software and serviceproviders, to be $400 million to $1 billion within the next threeto five years

Annealing technology represents near-term quantum tech that issolving enterprise optimization problems today for key industries

D-Wave’s quantum computing systems and services are exploring andaddressing computationally complex problems, including supply chainoptimization, fraud detection, and employee scheduling

New trends in technology are creating high demand for solutionsthat can solve increasingly computationally complex problems. That,coupled with accelerated adoption of artificial intelligence andmachine learning, are some of the main factors currently drivingquantum computing market growth. Boston Consulting Group estimatesthe near-term TAM for quantum hardware, software and serviceproviders, to be $400 million to $1 billion within the next threeto five years.D-Wave (NYSE: QBTS) is a leader in quantum computing systems, software and servicesand the world’s first commercial supplier of quantum computers. Thecompany today introduced a new hybrid solver plug-in for featureselection as part of its focus on helping companies leveragequantum technology to streamline development of machine learning(“ML”) applications. D-Wave’s new hybrid solver plug-in for theOcean(TM) SDK allows developers to more easily incorporate quantuminto feature selection/ML workflows. “We’re hearing from customersthat the combination of quantum hybrid solutions with featureselection in AI/ML model training is important for acceleratingbusiness impact,” said Murray Thom, vice president of quantumbusiness innovation at D-Wave. “This plug-in represents yet anotherexample of how D-Wave is facilitating quantum ML workstreams andmaking it easy to incorporate optimization in feature selectionefforts.” To view the full press release, visit

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer


With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service


D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Monday's trading session at $0.4935, off by 4.2863%, on 594,180 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.491/$13.23.

Recent News

India Globalization Capital Inc. (NYSE American: IGC)

The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital Inc. (NYSE American: IGC).

India Globalization Capital (NYSE American: IGC) (dba IGC Inc.) will begin operating under the name IGC Pharma Inc.(dba IGC), effective March 30, 2023; the name change is one aspectof the company’s rebranding strategy designed to better reflect itsstrategic focus and vision for the future. IGC’s common stock willtrade on NYSE American exchange under the new name on March 31,2023; the symbol will remain the same: IGC. According to theannouncement, the change in name to IGC Pharma better representsthe company’s focus as a developer of drug assets for treatingdiseases, including but not limited to Alzheimer’s disease. IGC iscurrently developing what it believes is the first natural,cannabis-based, patent-protected compound that relies on low dosesof THC and another compound as pharmaceutically active agents(“APIs”) for the treatment of Alzheimer’s disease. Theinvestigational medication, IGC-AD1, is currently in a phase 2trial. “Our business has gone through a transformation over thepast several years, and changing our name to IGC Pharma Inc. (dbaIGC) represents a major milestone by now clearly aligning our namewith our strategic focus as a leading developer and provider ofTHC-based drug assets,” said IGC Pharma CEO Ram Mukunda in thepress release. “We’re encouraged by the performance of ourinvestigational drug candidate, IGC-AD1, in FDA trials on agitationin Alzheimer’s, and our consumer products continue to gain tractionin the market. Given our progress, we felt it made sense to rebrandand rename our company to more accurately reflect our businessfocus, our research and development progress in the phase 2clinical trial on Alzheimer’s and our strategic vision.” To viewthe full press release, visit A Florida House Committee has unanimously approved a measure thatwould allow the use of telehealth in certain aspects of cannabistreatment. Bill HB 387 would make it possible for doctors to use telehealth to renewtheir patients’ medical cannabis approvals. According to sponsorRep Spencer Roach, the bill would treat medical cannabis like anyother pharmaceutical. Venice-based physician Dr. Barry Gordon toldthe House Health Care Regulation Subcommittee before the vote that leveraging telehealth to renew medicalcannabis certifications would benefit the most vulnerableFloridians. As dozens of states have legalized marijuana formedical use, millions of people across the country have signed upfor medical cannabis access. A large portion of these medicalcannabis patients (32.5%) are aged 50 to 64 years of age, and medical cannabis use amongolder people has been steadily increasing as the drug loses its stigma. As the users of medical marijuanaincrease by the day, another noteworthy trend is the increasingamount of R&D work being undertaken by for-profit entities suchas India Globalization Capital Inc. (NYSE American: IGC) in a bid to commercialize pharmaceutical-grade. cannabis-basedformulations that meet the strict requirements of the FDA.

India Globalization Capital Inc. (NYSE American: IGC), through subsidiary IGC Pharma, develops, patents, and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases including but not limited to Alzheimer’s disease, Tourette syndrome, chronic pain, and pet seizures.

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia, the first study in humans of a natural tetrahydrocannabinol (THC) compound plus another molecule ( As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC-based formulation on Alzheimer’s patients.

The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines. Both drug candidates have shown their ability to ameliorate beta amyloid plaques in Alzheimer’s cell lines and improve memory in Alzheimer’s mouse models. Beta amyloid plaques are a key hallmark of Alzheimer’s and an important target of Alzheimer’s pharmaceutical drug development.

Neuro Psychiatric Symptoms (NPS) are not only debilitating for Alzheimer’s patients; they also place an immense emotional burden on their caregivers. Beyond reducing symptoms, IGC-AD1’s active molecules and TGR-63 have also shown promise in preclinical trials to reduce important hallmarks of Alzheimer’s including plaques and tangles, as well as improving the treatment of memory loss.

Over the past eight years, the IGC team has amassed a deep knowledge of cannabinoid science, including extraction, isolation, purification, and development. The company’s strategy is to leverage its unique end-to-end capabilities, platform, and expertise to develop a class-leading program and bring it to market quickly and cost efficiently to treat neurodegenerative diseases such as Alzheimer’s.

The company also has a family of cannabidiol (CBD)-based consumer products ( such as pain relief creams, pain relief gels, purpose gummies, tinctures, and capsules targeting women’s wellness, with a particular focus on premenstrual syndrome (PMS) and dysmenorrhea (period cramps). In addition, the company targets individuals that need sleep-aids with its specially formulated low melatonin cannabinoid gummies.

IGC has also introduced a low-calorie CBD- and caffeine-infused energy beverage brand ( that is currently available for purchase. The company’s brands are founded on the belief that effective natural solutions should be affordable and accessible to everyone. As the demand for natural products targeting women’s wellness and energy drinks continue to grow, these products are seeing strong traction in the market.

The company operates three facilities – a large GMP (Good Manufacturing Production Standards) certified facility that includes extraction, distillation, and manufacturing, in Washington State; a GMP-211 (pharmaceutical) grade facility in Maryland; and a facility licensed for controlled substances including cannabis in Bogota, Colombia, with complete access to legal licensed cannabis where the company conducts its testing.

In addition, the company’s development under Magistral Formulations is approved by INVIMA (Colombia National Food and Drug Surveillance Institute) to treat neurological disorders, non-oncological chronic pain, and mental disorders.

IGC’s intellectual property (IP) portfolio comprises of eight patents that it controls and seven patent applications. The portfolio includes #11,446,276, a patent for extreme low dose THC treatment of Alzheimer’s that was granted in September 2022.

The company is headquartered in Potomac, Maryland.


IGC-AD1 is the company’s leading drug candidate for the treatment and relief of Alzheimer’s symptoms. A significant amount of research on Alzheimer’s cell lines has shown that the active agents in IGC-AD1 reduce plaques and neurofibrillary tangles that are the hallmarks of Alzheimer’s. Further, micro-dosing of THC, as shown in cell lines, could increase the functioning of mitochondria and potentially promote the growth of new neural pathways (neurogenesis). The research shows that micro-dosing of THC affects the brain radically differently from the normal higher dosing of THC.

While there is a significant body of research showing that THC is neuro-toxic at normal levels of dosing, micro-dosing of THC has been shown to be non-toxic to neurons. With the results of these preclinical studies, the company developed an oral formulation, IGC-AD1. The company recently completed a safety and tolerability Phase 1 trial on Alzheimer’s patients and has initiated a Phase 2, multi-site, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer’s disease at sites in the U.S. and Canada. IGC expects the Phase 2 trial to take between 9 and 12 months to complete, barring unknown factors such as, for example, a resurgence of COVID and the enforcement of lockdowns and travel restrictions.

With further successful trials and FDA approvals, IGC hopes to bring a drug based on natural THC as an effective treatment for agitation in Alzheimer’s to market.


The company’s other molecule, TGR-63, has been shown to reduce the neurotoxicity that impacts memory loss in preclinical trials with mice. On a dose dependent manner, transgenic Alzheimer’s mice treated with TGR-63 showed improvement in memory relative to control.

Both drug candidates, IGC-AD1 and TGR-63, have shown their ability to reduce the brain plaques associated with memory loss in Alzheimer’s in mice.

With further successful trials and FDA approvals, IGC hopes to bring TGR-63 as a treatment for Alzheimer’s disease to market.

Market Opportunity

Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. Over 70% of these patients face debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.

In 2020, the estimated healthcare costs for Alzheimer’s disease in the U.S. were $305 billion. Medicare and Medicaid covered about 70% of those costs, leaving considerable burden on patients and families. At the current rate of growth of Alzheimer’s and other dementia diagnoses, those costs are estimated to reach over $1 trillion by 2050.

Currently, there are no FDA-approved medications to alleviate the symptoms of dementia due to Alzheimer’s disease, providing a tremendous opportunity for formulations that can have an impact on quality of life and disease progression.

Management Team

Richard Prins has been chairman at IGC since 2012 and served as an independent director since 2007. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated. Prins served in a consulting role to RBC until January 2009. He currently volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals Inc. He holds a bachelor’s degree from Colgate University and an MBA from Oral Roberts University.

Ram Mukunda is CEO and President of IGC. He has been the chief inventor and architect of most of the company’s patent filings and is responsible for the company’s strategic positioning. Prior to IGC, he was founder and CEO of Startec Global Communications, which he took public in 1997. He served as Strategic Planning Advisor at Intelsat, a communications satellite services provider. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. He was named the 1998 Ernst & Young Entrepreneur of the Year. He holds bachelor’s degrees in electrical engineering and mathematics, and a master’s degree in engineering from the University of Maryland.

Dr. Jagadeesh Rao is the company’s Principal Scientist. His career spans two decades in the public sector and product R&D for Johnson & Johnson. He leads IGC’s scientists in the development of pharmaceutical and OTC products. He worked for the federal National Institutes of Health, and for the National Institute on Drug Abuse. His Ph.D. in Neurochemistry is from the National Institute of Mental Health & Neurosciences in India. He did postdoctoral training at the University of Illinois-Chicago.

Claudia Grimaldi is a Director, Vice President, Principal Financial Officer, and Chief Compliance Officer for IGC. She also serves as a Director/Manager Director for some of the company’s subsidiaries. She graduated with highest honors from Javeriana University in Colombia with a bachelor’s degree in psychology. She holds an MBA, graduating with highest honors, from Meredith College in North Carolina. In addition, she has attended the Darden School of Business Financial Management Executives program and the Corporate Governance Program at Columbia Business School. She is currently pursuing her Directorship Certification with the National Association of Corporate Directors. She is fluent in both English and Spanish.

India Globalization Capital Inc. (NYSE American: IGC), closed Monday's trading session at $0.332, off by 2.3817%, on 103,772 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2785/$1.16.

Recent News

CISO Global, Inc. (NASDAQ: CISO)

The QualityStocks Daily Newsletter would like to spotlight CISO Global, Inc. (NASDAQ: CISO).

Cerberus Cyber Sentinel Corporation (“Cerberus Sentinel” or the “Company”) (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider, based in Scottsdale, Ariz., today announced certain preliminary estimated financial information as of and for the quarter and fiscal year ended December 31, 2022.
The preliminary estimated financial information has been prepared by, and is the responsibility of, the Company’s management. Semple, Marchal & Cooper, LLP, the Company’s independent registered public accounting firm, has not audited, reviewed, compiled or performed any procedures with respect to the preliminary estimated financial information provided below.
The Company’s preliminary unaudited estimates for the fourth quarter and fiscal year ended December 31, 2022 are as follows:

$14.7 million in total revenue for the fiscal quarter ended December 31, 2022, an increase of $8.8 million, or 150%, compared to total revenue of $5.9 million for the fiscal quarter ended December 31, 2021.
$46.5 million in total revenue for the fiscal year ended December 31, 2022, an increase of $31.4 million, or 207%, compared to total revenue of $15.1 million for the fiscal year ended December 31, 2021.
$9.4 million in operating loss for the fiscal quarter ended December 31, 2022, a decrease of $23.5 million, or 71%, compared to $32.9 million in operating loss for the fiscal quarter ended December 31, 2021.
$33.2 million in operating loss for the fiscal year ended December 31, 2022, a decrease of $6.6 million, or 17%, compared to $39.8 million in operating loss for the fiscal year ended December 31, 2021.

CISO Global, Inc. (NASDAQ: CISO) is an industry leader in cybersecurity and compliance services. The company leverages an integrated approach to reduce noise and bridge common silos that often limit the effectiveness of cybersecurity programs. Pulling disparate technologies, teams, and vendors together, CISO helps its clients enjoy a simpler and more successful journey to cyber resilience. Since 2019, CISO Global has worked to rapidly expand by acquiring world-class cybersecurity and compliance businesses with top-tier talent who utilize the latest technology to create innovative protection solutions.

The CISO Global workforce is comprised of cybersecurity experts spanning not only global geographies, but also specialties, industries, regulatory frameworks and focus areas. Its team includes audit and compliance specialists, certified forensics experts, ethical hackers, IEEE® certified biometric professionals, security engineers, around-the-clock analysts, and more – all backed by the most respected credentials in the industry. On an ongoing basis, the company works to identify cyber talent that is culturally aligned and that offers operating leverage through both existing customer revenue and relationships.

CISO Global has invested in enterprise solutions and executive talent to integrate its different organizations into an ecosystem that works together to provide complete cybersecurity through cross-pollination of solutions that begin at the network level and extend through technologies, people, policy, and practices. This ecosystem is intended to foster additional growth opportunities and drive overall recurring revenue. Once engaged, the company strives to become trusted advisors for customers’ cybersecurity and compliance demands by providing tailored security solutions based upon their organizational needs.

While cyber resilience requires cycles of continuous improvement, it is a journey that few in the current business and security climate seem to understand. With its deep bench of seasoned experts, CISO Global works to simplify that journey for its growing customer base, straightening out the curves and speeding up the process to resilience along the way.

Cybersecurity is a Culture, Not a Product

Integrating compliance and security, including principles of security by design, CISO Global helps its clients create an organization-wide culture of cybersecurity. Its offerings include audit and compliance, security operations center services, security engineering, virtual Chief Information Security Officer services, incident response, certified forensics, technical assessments and cybersecurity training.

In contrast to the majority of cybersecurity firms that specialize in a specific technology or service, CISO Global seeks to differentiate itself by remaining technology agnostic, focusing on accumulating highly sought-after subject matter experts. CISO Global believes that bringing together a world-class team of technological experts with multi-faceted proficiency in the critical aspects of cybersecurity is key to providing technology agnostic solutions to its clients in a business ecosystem that suffers from a chronic lack of highly skilled professionals.

CISO Global’s goal is to create a culture of security and to help quantify, define and capture a return on investment from information technology and cybersecurity spending. Its end-to-end, holistic process covers every aspect of clients’ cybersecurity and compliance requirements in an effort to promote greater efficiency and strengthen awareness about the integral role of internal team members in the cybersecurity culture of an organization.

As a result of this strategy, CISO Global customers receive an efficient engagement from a single partner that covers a wide range of their needs – addressing challenges more thoroughly and resolving problems more rapidly when compared to working with a host of vendors.

Market Outlook

According to an analysis by the firm Research and Markets, the global managed security services market was valued at $22.45 billion in 2020 and is projected to reach $77.01 billion by 2030, growing at a CAGR of 12.8% through the forecast period.

An expected increase in cybercrime, cost effectiveness of provided solutions and stringent mandatory government regulations aimed at protecting corporate data will drive the global managed security services market for the foreseeable future.

In addition, the documented and growing use of mobile devices in the workplace and the rise in captured and stored digital data serve to fuel market growth. Moreover, growing awareness about the critical nature of data security, the growing importance of e-business and demand for customized services is expected to offer ample opportunities for expansion of the market during the forecast period.

Management Team

David Jemmett is CEO and founder of CISO Global. He has more than 35 years of executive management and technology experience with telecommunications, managed services, and cybersecurity consulting services. He previously held positions as CEO of GenResults, a leading provider of security consulting services and technology solutions, and as CTO and founder at ClearData Networks, a HIPAA-compliant HealthDATA cloud hosting platform.

Dave Bennett is COO at CISO Global. Since 2015, he has served on the President’s STEM Advisory Board of Grand Canyon University. Before joining CISO Global, he served as Chief Product Officer at Experian Health and as Senior Vice President, Product for Gainwell Technologies. He has also held positions as Vice President and Worldwide Head of Build, Healthcare and Life Sciences at DXC Technology, and as EVP, Product and Strategy at Orion Health.

Ashley Devoto is President and Chief Information Security Officer at CISO Global. Over the past 17 years, Devoto has worked with the cybersecurity elite to design, build, and operate world-class cybersecurity programs for large, diverse organizations in both government and commercial enterprises. Prior to joining CISO, Devoto served as CISO for Booz Allen Hamilton, as business information security officer (BISO) at Bank of America, and as a cyberspace operations officer in the United States Air Force.

Deb Smith is CFO at CISO Global. Prior to assuming that position, she was the company’s EVP, Finance and Accounting. She has also served as SVP, Global Accounting at International Cruise and Excursions Inc., and as Chief Accounting Officer for BeyondTrust, an information security software company. She has also held the positions of Corporate Controller at Aspect Software and Assistant Controller at JDA Software.

CISO Global, Inc. (NASDAQ: CISO), closed Monday's trading session at $2.05, up 3.0151%, on 73,251 volume with 375 trades. The average volume for the last 3 months is 57,207 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

Advanced Container Technologies’ (OTC: ACTX) innovative controlled environment farms – GrowPods – enable almostanyone to start growing leafy greens and certain vegetables 365days a year in any environment. GrowPods are insulated, heated andcooled and can provide year-round, fresh produce for businesses,community groups, entrepreneurs, restaurants, grocery stores, andfarmers. Even traditional farmers use GrowPods to supplement theirincome to cultivate high-profit herbs and produce year-round. ABCNews in Denver reported that shipping container farming providesthe opportunity to “grow anything, anywhere at any time,” includingthe upside of controlled environment farms located in urban areasto provide food to local restaurants and grocery stores. “Lookingat a Colorado used car lot from the street, you see nothing but ashipping container. However, when you step inside, it suddenlyfeels like the future,” ABC reported. To view the full pressrelease, visit A bipartisan pair of congressional lawmakers has refiled a draftlaw meant to address the growing problem of illicit cannabis plantations on federal land. The lawmakers framed the legislation as a much-needed tool forthe government to rein in illegal cannabis grows that are polluting the environment and risking marijuana consumers’ health. Although dozens of stateshave launched medical and recreational cannabis markets, America’s illicit cannabis market is still thriving. Licensed sellers struggle to compete with the illicit market ashigh taxes, and rigid rules have made legal cannabis several times more expensive than black-market marijuana. As a result, the illicit market regularly outsells the legal market by a wide margin, robbing states of tax revenue and feedingbillions of dollars into the criminal enterprises behind theillicit cannabis market. Furthermore, illegal cannabis grows oftenuse toxic banned pesticides and herbicides, which can leach into the ground and contaminate water sources. Cannabis consumers who use illicit cannabis also face the risk ofcontamination and adverse health effects from consuming low-qualityor contaminated cannabis. If more of these illicit cultivatorsbecame licensed participants in the regulated cannabis market, theycould benefit from new technologies such as the microgardens soldby Advanced Container Technologies Inc. (OTC: ACTX) to grow cannabis in an environmentally responsible way.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.


Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.


ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Monday's trading session at $0.1395, off by 56.5421%, on 6,780 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.1261/$1.25.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is partneringwith Qiantu Motors to launch the DragonFLY K50 in the Americas. Aspart of an exclusive licensing agreement, Qiantu Motors andaffiliated companies granted MULN the North and South American IPand distribution rights allowing assembly and distribution. Theannouncement noted that Mullen will finalize vehicle engineering incompliance with U.S. regulations with final assembly planned forits Indiana-based manufacturing facility. The EV supercar will besold under the Mullen GT & GTRS brands with performance specsanticipated to include going from 0 to 60 miles per hour in 1.95seconds and with a top speed of more than 200 mph, thus ensuringits supercar status. Mullen noted that it will commence thereengineering and redesigning modifications, which will be in linewith Mullen’s vehicle design language currently found in the MullenFIVE and Mullen FIVE RS. “This agreement with Qiantu is animportant milestone for the company,” said Mullen CEO and chairDavid Michery in the press release. “Not only does it settle a longoutstanding dispute between our respective companies but alsopresents the opportunity to fulfill my vision for a supercar thatwould rival some of the best supercars in the world. Since day one,we have received overwhelming positive feedback for this vehicle,including our original debut at the 2019 New York Auto Show and theIndy 500 in May 2019. We are excited to start the GT and GTRSprograms on March 20, 2023.” To view the full press release, visit

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Monday's trading session at $0.132, off by 2.3669%, on 287,509,154 volume. The average volume for the last 3 months is 104,114 and the stock's 52-week low/high is $0.125/$4.1799.

Recent News

Progressive Care Inc. (OTCQB: RXMD)

The QualityStocks Daily Newsletter would like to spotlight Progressive Care Inc. (OTCQB: RXMD).

Progressive Care Inc. (OTCQB: RXMD) is a health services organization based in Florida that offers personalized healthcare services and technology that supports the managed healthcare industry. Through its subsidiaries, Progressive Care provides Third-Party Administration (TPA), data management and analytics, COVID-19 diagnostics and vaccinations, 340B contracted pharmacy services, compounded medications, tele-pharmacy services, dispensing of anti-retroviral medications, medication therapy management (MTM), long-term care facility-targeted prescription medications, and health practice risk management.

The company collaborates with various healthcare organizations such as managed care organizations (MCOs), management services organizations (MSOs), accountable care organizations (ACOs), primary care providers, Medicare Advantage plans, Medicaid, commercial payors, pharmaceutical manufacturers, and distributors to enhance patient and provider engagement while improving the lives of patients with chronic diseases. Progressive Care offers a wide range of innovative solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs.

Progressive Care currently operates four pharmacies in Florida, which generate the majority of its revenue. Pharmacy revenue is derived from dispensing medications, third-party administrative services to 340B-covered entities, and MTM services. The company also provides customized management, patient health risk reviews, and free same- and next-day delivery. Its focus is on complex chronic diseases that require multiyear or lifelong therapy, driving recurring revenue and sustainable growth. Progressive Care’s pharmacy revenue growth stems from its expanding breadth of services, new drugs coming to market, new indications for existing drugs, volume growth with current clients, and addition of new customers resulting from its emphasis on higher patient engagement, free delivery to the patient, and clinical expertise.

With licenses in 14 states, Progressive Care is poised for national expansion. The company anticipates revenue growth by signing new contract pharmacy service and data management contracts with 340B-covered entities, expanding data management and analytics services to healthcare organizations, and potential acquisitions.


Progressive Care’s wholly-owned subsidiaries provide services to client organizations and patients.

PharmcoRx Pharmacy

PharmcoRx, a full-service pharmacy, provides a complete healthcare ecosystem with services such as medication therapy management, rapid COVID-19 testing and vaccines, contactless medication delivery, Smart-Pack Unit Dosing packaging, custom compound medications, specialty medications, hospital transition pharmacy services, medication adherence monitoring, medication adherence risk management, and drug cost containment. PharmcoRx Pharmacy is a contracted pharmacy services provider for 340B-covered entities under the 340B Drug Discount Pricing Program.


ClearMetrX, a wholly-owned data management company, offers services that support healthcare organizations across the country. In September 2022, ClearMetrX launched the 340MetrX Platform, a software product developed by ClearMetrX that provides 340B-covered entities with data insights to effectively operate and maximize the benefits of the 340B program. 340MetrX supplies data access and delivers actionable insights that providers and support organizations can use to improve their practices and patient care. Its TPA services include management of wholesale accounts and contract pharmacies, patient eligibility with regard to the 340B drug program, development and review of 340B policies and procedures, and management of receivables.

Market Opportunity

According to an industry report by global consulting firm Berkeley Research Group, gross sales across the 340B drug program were valued at $116 billion in 2021 and are projected to grow to $280 billion by 2026, achieving a CAGR of more than 19% over the period.

The 340B drug pricing program allows eligible healthcare clinics and hospitals (the covered entities) to purchase outpatient drugs at a 20-50 percent discount to treat low-income, uninsured, or underinsured populations. The program’s forecast growth is expected to benefit Progressive care’s business of providing 340B program services to covered entities through the nationwide expansion of ClearMetrX, its third-party administration and data-management business.

Management Team

Charles M. Fernandez is CEO and Chairman of the Board of Directors of Progressive Care. Mr. Fernandez is also the Executive Chairman and CEO of NextPlat Corp. (NASDAQ: NXPL) and has over 30 years of experience in identifying profitable start-up and dislocation opportunities, building significant value and executing exit strategies as an entrepreneur and global investor. In 2008, he joined Fairholme Capital Management. As president, he co-managed all three Fairholme funds and was commended for bringing in a $2 billion gain for shareholders. Throughout his impressive career in media, pharmaceuticals, healthcare, finance and technology, Mr. Fernandez has participated in more than 100 significant mergers, acquisitions and product development projects. He was the founder, chairman and CEO of eApeiron Solutions LLC, a brand protection and e-commerce company in partnership with Alibaba (NYSE: BABA) and Eastman Kodak (NYSE: KODK) which was successfully sold to Smartrac, a leading developer, manufacturer and supplier of RFID and Internet of Things (“IoT”) solutions and a unit of Avery Dennison Corporation (NYSE: AVY).

Other top management team members include Chief Operating Officer Birute Norkute, Chief Financial Officer Cecile Munnik, and Pamela Roberts, who serves as the company’s Pharmacist in Charge.

FingerMotion Inc. (RXMD), closed Monday's trading session at $4, off by 7.6212%, on 553 volume. The average volume for the last 3 months is 5,999 and the stock's 52-week low/high is $3.40/$10.40.

Recent News

Utopia VR

The QualityStocks Daily Newsletter would like to spotlight Utopia VR

Utopia VR is one of the world’s first ‘Metaverse-As-A-Service’ solutions for business. The company’s hosted and managed subscription software provides businesses a low barrier to entry, browser-based, device agnostic platform where they can manage their own private 3D metaverse meeting spaces. Users can host and attend Zoom-like virtual meetings in lifelike virtual reality – with no software downloads – engaging their audiences in a more collaborative and fun way.

Utopia VR has many technology and privacy advantages over solutions built on other metaverse marketplaces such as Horizon Worlds (META) or Decentraland. Utopia VR works on all devices – PC, mobile and virtual reality headsets – whereas many competitors only work in VR or on PC.

Utopia VR is headquartered in Kelowna, B.C.


Utopia VR’s The Metaverse for Everyone™ is a one-click, web-based, avatar-driven, mobile-friendly audio- and video-conferencing platform that utilizes innovative 3D web technology. Utopia VR’s virtual platform works on digital devices including PCs, mobile phones and VR headsets such as Oculus Quest or HTC Vive. No software or proprietary hardware is needed.


Users navigate through the various VRoom environments by using avatars. Users can walk, talk and sit – just like they do in the real world. A user’s avatar can be controlled with a computer keyboard, smartphone or virtual reality headsets. Text chat, voice and video is ever-present and used to communicate with others in the VRoom. For important meetings and presentations, users can also import audio, video, 2D art and images, animated 3D objects, PDF files and their favorite NFTs by simply dragging and dropping files into a VRoom or pasting a video link from supported media platforms.

Organizations that have an existing website can transition their digital assets, including text, images, video, PDFs, slideshows and more, to VRoom environments with a simple copy and paste. This will allow their customers and audiences to experience their brand in a whole new, immersive environment.
Utopia VR’s mobile app enables users to personalize their own 3D environments and then schedule business meetings or social meetups in seconds through a proprietary link management system. The app is available for iPhone and iPad users. The company’s website mirrors the app, which means users can access Utopia VR directly from a PC, laptop, tablet, or VR headset without downloading the app.

Market Outlook

Regarded as the next iteration of the internet, the metaverse is a virtual space where the physical and digital worlds coexist and interact, encompassing virtual reality, augmented reality, extended reality and mixed reality, as well as making use of artificial intelligence and other technologies.

Data consolidator Statista estimated that the global metaverse market size stood at $38.85 billion in 2021 and projected the market would grow to be worth $47.48 billion in 2022. From there, Statista forecasts the value of the metaverse market will explode to reach $678.8 billion by 2030, achieving a CAGR of more than 39% over the period.

The metaverse could create $5 trillion in opportunity by 2030, according to McKinsey & Company.

Management Team

Stuart Gray, President, Co-Founder and director of Utopia VR, has been an officer and director for both private and publicly traded companies and has led public offerings for junior listed companies that have gone on to realize multibillion-dollar market valuations. He previously was a consultant and quarterbacked taking eXp World Holdings Inc. (NASDAQ: EXPI) public. eXp is a disruptive, no bricks and mortar, real estate brokerage firm with 85,000 agents worldwide using its virtual, software-based, metaverse platform for closing transactions, training and events.

Cory Braden, CTO and director of Utopia VR, is a forward-thinking strategic leader with over 20 years of experience in delivering software as a service. Recognized for a positive leadership style and excellent communication skills, he is well-versed in user experience, complex application architectures, cloud infrastructure and management of high-performance teams.

Terry Woloszyn, VP of Sales and Advisory at Utopia VR, brings vast technical and sales experience to the company. Before joining Utopia VR, he conceived and launched a data security startup and graduated from two startup accelerator programs. He has personally raised $20 million in equity venture funding.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.